Cardax’s Astaxanthin Shows Breakthrough Longevity Results

Cardax announced earlier this month the breakthrough longevity results with its specialty formulated astaxanthin in a study conducted by the Interventions Testing Program (ITP).

ITP is supported by the National Institute on Aging which is part of the National Institutes of Health. The results of the study were published on December 2 in the high-impact longevity journal GeroScience.

The specialty-formulated astaxanthin is the same form used in Cardax’s dietary supplement Zanthosyn®.

Previously shown to increase the lifespan in yeast, roundworms and fruit flies, ITP extended the findings in mammals through this study that started in 2019 and ended this year. The study found astaxanthin extended the median lifespan of male mice by 12%.

In addition, the astaxanthin-treated group showed a consistent survival benefit versus control animals. Female mice’s median lifespan also increased but did not reach statistical significance.

Conducting actual lifespan studies in humans would require decades, so the ITP represents the most credible, practical assessment of mammalian lifespan presently available.

“Interventions with life extension benefits of more than 10% in the ITP are rare. Those that do, have side effects limiting chronic use for longevity,” says Dr. Bradley J. Wilcox, MD, world-renowned Harvard-trained longevity researcher at the University of Hawaii’s John A. Burns School of Medicine. He is the scientific advisor to Cardax and co-author of the GeroScience paper reporting on these results.

“Astaxanthin is also commercially available and relatively inexpensive,” added Dr. Wilcox.

Cardax chairman and CEO said: “This rigorous, highly selective, and independent study adds to the body of evidence supporting astaxanthin’s longevity benefits. We have been working with astaxanthin for 25 years and our mission is to grow the awareness of its potential to slow aging and help people continue doing what they love.”

Cardax is a geroscience company focused on pharmaceutical and nutraceutical applications of astaxanthin. The company markets Zanthosyn®, a physician-recommended astaxanthin dietary supplement for lifespan and healthspan, including joint and muscle function, cognitive performance and cardiovascular health.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.